UB Paderborn / Katalog / Suche / in CDI

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives

Frontiers in oncology, 2022-03, Vol.12, p.673094-673094

2022

Link zum Volltext

Verfügbarkeit prüfen

Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents

Therapeutic advances in medical oncology, 2020, Vol.12, p.1758835920953292-1758835920953292

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan

BMC women's health, 2020-06, Vol.20 (1), p.1-7, Article 118

2020

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look

Thrombosis journal, 2018-03, Vol.16 (1), p.2-2, Article 2

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS12-24: From clinical trials to clinical practice: Real-life outcome data of everolimus and exemestane in the treatment of patients with metastatic breast cancer

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS12-24-PS12-24

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-02-15: Thromboembolic events (TEE) in patients with HER2-negative, hormone receptor-positive metastatic breast cancer treated with Ribociclib combined with Letrozole or Fulvestrant. Real-world data

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-02-15

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-07-06: Guideline-based multi-gene panel (MGP) testing for germline pathogenic variants among patients diagnosed with breast cancer: Regional perspectives

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-07-06

2022

Link zum Volltext

Verfügbarkeit prüfen

From clinical trials to clinical practice: the use of everolimus and exemestane in the treatment of hormone receptor-positive metastatic breast cancer: real-world data

Journal of chemotherapy (Florence), 2022-04, Vol.34 (3), p.184-189

2022

Link zum Volltext

Verfügbarkeit prüfen

The practice of withholding and withdrawing life-support measures among patients with cancer in Jordan

International journal of palliative nursing, 2011-09, Vol.17 (9), p.440

2011

Link zum Volltext

Verfügbarkeit prüfen

Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges

Hospital Practice, 2023-10, Vol.51 (4), p.184-191

2023

Link zum Volltext

Verfügbarkeit prüfen

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data

Cancer management and research, 2022-01, Vol.14, p.1033-1041

2022

Link zum Volltext

Verfügbarkeit prüfen

From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer

Breast cancer research and treatment, 2017-10, Vol.165 (3), p.771-777

2017

Link zum Volltext

Verfügbarkeit prüfen

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer

Breast cancer targets and therapy, 2023-01, Vol.15, p.1-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country

Cancer management and research, 2019-11, Vol.11, p.9891-9897

2019

Link zum Volltext

Verfügbarkeit prüfen

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

OncoTargets and therapy, 2018-01, Vol.11, p.2091-2096

2018

Link zum Volltext

Verfügbarkeit prüfen

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

OncoTargets and therapy, 2018-01, Vol.11, p.2091

2018

Link zum Volltext

Verfügbarkeit prüfen

Inferior vena cava filters in cancer patients: to filter or not to filter

Therapeutics and clinical risk management, 2011-01, Vol.7 (default), p.99-102

2011

Link zum Volltext

Verfügbarkeit prüfen

Cancer Related Anemia in the Era of Erythropoietin Stimulating Agents (ESA)Uncertainty: A Single Cancer Institution Experience

Blood, 2009-11, Vol.114 (22), p.5085-5085

2009

Link zum Volltext

Verfügbarkeit prüfen

The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center

Hematology/oncology and stem cell therapy, 2010-04, Vol.3 (2), p.78-83

2010

Link zum Volltext

Verfügbarkeit prüfen

Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours

Nuklearmedizin. Nuclear medicine, 2016-08, Vol.55 (4), p.N34

2016

Link zum Volltext

Verfügbarkeit prüfen

STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations

Pharmaceuticals (Basel, Switzerland), 2023-07, Vol.16 (8), p.1080

2023

Link zum Volltext

Verfügbarkeit prüfen

Social Loafing and Job Performance in Hotels: Does Transactional Leadership Matter?

African journal of hospitality, tourism and leisure, 2024-03, Vol.13 (1), p.192-197

2024

Link zum Volltext

Verfügbarkeit prüfen

Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa

Travel medicine and infectious disease, 2021-07, Vol.42, p.102064-102064, Article 102064

2021

Link zum Volltext

Verfügbarkeit prüfen

Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study

Drug design, development and therapy, 2013-01, Vol.7 (default), p.939-944

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Rates of Variants of Uncertain Significance Among Patients With Breast Cancer Undergoing Genetic Testing: Regional Perspectives

Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents

Tumor characteristics and treatment outcomes of older patients with breast cancer in Jordan

Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look

Abstract PS12-24: From clinical trials to clinical practice: Real-life outcome data of everolimus and exemestane in the treatment of patients with metastatic breast cancer

Abstract P4-02-15: Thromboembolic events (TEE) in patients with HER2-negative, hormone receptor-positive metastatic breast cancer treated with Ribociclib combined with Letrozole or Fulvestrant. Real-world data

Abstract P3-07-06: Guideline-based multi-gene panel (MGP) testing for germline pathogenic variants among patients diagnosed with breast cancer: Regional perspectives

From clinical trials to clinical practice: the use of everolimus and exemestane in the treatment of hormone receptor-positive metastatic breast cancer: real-world data

The practice of withholding and withdrawing life-support measures among patients with cancer in Jordan

Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges

Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data

From clinical trials to clinical practice: outcome of NSABP-B27 neoadjuvant chemotherapy regimen for high-risk early-stage breast cancer

Guideline-Based, Multi-Gene Panel Germline Genetic Testing for at-Risk Patients with Breast Cancer

Clinicopathological Characteristics And Treatment Outcomes Of Breast Cancer Among Adolescents And Young Adults In A Developing Country

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

Inferior vena cava filters in cancer patients: to filter or not to filter

Cancer Related Anemia in the Era of Erythropoietin Stimulating Agents (ESA)Uncertainty: A Single Cancer Institution Experience

The impact of recently published negative erythropoiesis-stimulating agent studies on the clinical management of cancer-related anemia at a single center

Synchronous presentation of nasopharyngeal carcinoma and abdominal paraganglioma with avid 18F-FDG and 68Ga-DOTA-TOC uptake in PET/CT by both tumours

STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations

Social Loafing and Job Performance in Hotels: Does Transactional Leadership Matter?

Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa

Intravenous iron monotherapy for the treatment of non-iron-deficiency anemia in cancer patients undergoing chemotherapy: a pilot study

Suchergebnisse filtern